{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:46:42Z","timestamp":1740142002045,"version":"3.37.3"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006751","name":"US Department of the Army","doi-asserted-by":"publisher","award":["HT94252310829"],"award-info":[{"award-number":["HT94252310829"]}],"id":[{"id":"10.13039\/100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000182","name":"Medical Research and Materiel Command","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cct.2024.107741","type":"journal-article","created":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T23:22:13Z","timestamp":1731280933000},"page":"107741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design and methodology of a randomized clinical trial of quetiapine to reduce central nervous system polypharmacy in veterans with postconcussive syndrome symptoms"],"prefix":"10.1016","volume":"147","author":[{"given":"Muhammad R.","family":"Baig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Villarreal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizette","family":"Aviles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeel","family":"Meraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betsy","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric C.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey","family":"Straud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Young-McCaughan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan L.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Roache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2008","series-title":"Invisible Wounds of War: Psychological and Cognitive Injuries, their Consequences, and Services to Assist Recovery","key":"10.1016\/j.cct.2024.107741_bb0005"},{"issue":"7","key":"10.1016\/j.cct.2024.107741_bb0010","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/13803395.2019.1610161","article-title":"Evaluation of objective and subjective clinical outcomes in combat veterans with and without mild TBI and PTSD: a four-group design","volume":"41","author":"Merritt","year":"2019","journal-title":"J. Clin. Exp. Neuropsychol."},{"article-title":"Managment and rehabilitation of post-acute Mild Traumatic Brain Injury (mTBI)","year":"2021","series-title":"Clinical Practice Guidelines","key":"10.1016\/j.cct.2024.107741_bb0015"},{"year":"2013","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"Association, A.P","key":"10.1016\/j.cct.2024.107741_bb0020"},{"issue":"7","key":"10.1016\/j.cct.2024.107741_bb0025","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.biopsych.2017.03.007","article-title":"It is time to address the crisis in the pharmacotherapy of posttraumatic stress disorder: a consensus statement of the PTSD psychopharmacology working group","volume":"82","author":"Krystal","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.cct.2024.107741_bb0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1176\/appi.ps.201000531","article-title":"Pharmacotherapy regimens among patients with posttraumatic stress disorder and mild traumatic brain injury","volume":"63","author":"Morgan","year":"2012","journal-title":"Psychiatr. Serv."},{"issue":"1","key":"10.1016\/j.cct.2024.107741_bb0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40801-015-0055-0","article-title":"Prevalence of central nervous system polypharmacy and associations with overdose and suicide-related behaviors in Iraq and Afghanistan war veterans in VA care 2010-2011","volume":"3","author":"Collett","year":"2016","journal-title":"Drugs Real World Outcomes"},{"issue":"3","key":"10.1016\/j.cct.2024.107741_bb0040","first-page":"223","article-title":"Posttraumatic stress symptoms in OIF\/OEF service members with blast-related and non-blast-related mild TBI","volume":"26","author":"Kennedy","year":"2010","journal-title":"NeuroRehabilitation"},{"issue":"2","key":"10.1016\/j.cct.2024.107741_bb0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pnpbp.2008.12.004","article-title":"Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review","volume":"33","author":"Berger","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.cct.2024.107741_bb0050","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00003495-200464040-00004","article-title":"SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations","volume":"64","author":"Asnis","year":"2004","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.cct.2024.107741_bb0055","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1682\/JRRD.2008.09.0120","article-title":"Pharmacological management of neurobehavioral disorders following traumatic brain injury--a state-of-the-art review","volume":"46","author":"Chew","year":"2009","journal-title":"J. Rehabil. Res. Dev."},{"issue":"6","key":"10.1016\/j.cct.2024.107741_bb0060","first-page":"2","article-title":"Polypharmacy involving opioid, psychotropic, and central nervous system depressant medications, period prevalence and association with suicidal ideation, active component, U.S. armed forces, 2016","volume":"25","author":"Eide","year":"2018","journal-title":"Msmr"},{"issue":"3","key":"10.1016\/j.cct.2024.107741_bb0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00001199-200505000-00007","article-title":"Physical complaints, medical service use, and social and employment changes following mild traumatic brain injury: a 6-month longitudinal study","volume":"20","author":"Kraus","year":"2005","journal-title":"J. Head Trauma Rehabil."},{"issue":"2","key":"10.1016\/j.cct.2024.107741_bb0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/0033354916687748","article-title":"Traumatic brain injury incidence, clinical overview, and policies in the US military health system since 2000","volume":"132","author":"Swanson","year":"2017","journal-title":"Public Health Rep."},{"issue":"1","key":"10.1016\/j.cct.2024.107741_bb0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/HTR.0b013e31819581d8","article-title":"Traumatic brain injury screening: preliminary findings in a US army brigade combat team","volume":"24","author":"Terrio","year":"2009","journal-title":"J. Head Trauma Rehabil."},{"issue":"4","key":"10.1016\/j.cct.2024.107741_bb0080","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s11126-019-09668-7","article-title":"Enhancing access to psychiatric care for posttraumatic stress disorder in veterans with mild traumatic brain injury through integrated services","volume":"90","author":"Baig","year":"2019","journal-title":"Psychiatry Q."},{"issue":"1","key":"10.1016\/j.cct.2024.107741_bb0085","first-page":"46","article-title":"Quetiapine augmentation of prolonged exposure therapy in veterans with PTSD and a history of mild traumatic brain injury: design and methodology of a pilot study","volume":"7","author":"Baig","year":"2020","journal-title":"Mil. Med. Res."},{"issue":"4","key":"10.1016\/j.cct.2024.107741_bb0090","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jbct.2022.04.001","article-title":"Quetiapine as an adjunct to enhance engagement in prolonged exposure therapy for PTSD in veterans: a randomized, pilot trial","volume":"32","author":"Baig","year":"2022","journal-title":"J. Behav. Cogn. Therapy"},{"issue":"2","key":"10.1016\/j.cct.2024.107741_bb0095","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11126-019-09638-z","article-title":"Enhancing completion of cognitive processing therapy for posttraumatic stress disorder with quetiapine in veterans with mild traumatic brain injury: a case series","volume":"90","author":"Baig","year":"2019","journal-title":"Psychiatry Q."},{"issue":"2","key":"10.1016\/j.cct.2024.107741_bb0100","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00004714-199604000-00008","article-title":"ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL study group","volume":"16","author":"Borison","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.cct.2024.107741_bb0105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-5618.2004.00115.x","article-title":"Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study","volume":"6","author":"Sachs","year":"2004","journal-title":"Bipolar Disord."},{"issue":"7","key":"10.1016\/j.cct.2024.107741_bb0110","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1017\/S1461145710000015","article-title":"Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study","volume":"13","author":"El-Khalili","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.cct.2024.107741_bb0115","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00023210-200620050-00004","article-title":"Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia","volume":"20","author":"Horacek","year":"2006","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.cct.2024.107741_bb0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1037\/ccp0000059","article-title":"Augmenting cognitive processing therapy to improve sleep impairment in PTSD: a randomized controlled trial","volume":"84","author":"Galovski","year":"2016","journal-title":"J. Consult. Clin. Psychol."},{"issue":"4","key":"10.1016\/j.cct.2024.107741_bb0125","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.jcp.0000169624.37819.60","article-title":"Quetiapine improves sleep disturbances in combat veterans with PTSD: sleep data from a prospective, open-label study","volume":"25","author":"Robert","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.cct.2024.107741_bb0130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1176\/jnp.2006.18.4.547","article-title":"A pilot study of quetiapine treatment of aggression due to traumatic brain injury","volume":"18","author":"Kim","year":"2006","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.cct.2024.107741_bb0135","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00213-003-1759-5","article-title":"Sleep-promoting properties of quetiapine in healthy subjects","volume":"174","author":"Cohrs","year":"2004","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.cct.2024.107741_bb0140","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/TA.0000000000002866","article-title":"The neuroprotective effect of quetiapine in critically ill traumatic brain injury patients","volume":"89","author":"Asmar","year":"2020","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.cct.2024.107741_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2021.106583","article-title":"STRONG STAR and the consortium to alleviate PTSD: shaping the future of combat PTSD and related conditions in military and veteran populations","volume":"110","author":"Peterson","year":"2021","journal-title":"Contemp. Clin. Trials"},{"issue":"5\u20136","key":"10.1016\/j.cct.2024.107741_bb0150","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1093\/milmed\/usy226","article-title":"Common data elements in the assessment of military-related PTSD research applied in the consortium to alleviate PTSD","volume":"184","author":"Ben Barnes","year":"2019","journal-title":"Mil. Med."},{"issue":"3","key":"10.1016\/j.cct.2024.107741_bb0155","article-title":"Persistent postconcussion syndrome: the structure of subjective complaints after mild traumatic brain injury","volume":"10","author":"Cicerone","year":"1995","journal-title":"J. Head Tr Rehabil."},{"issue":"6","key":"10.1016\/j.cct.2024.107741_bb0160","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/jts.22243","article-title":"Examination of the World Health Organization disability assessment system as a measure of disability severity among veterans receiving cognitive processing therapy","volume":"30","author":"Schumm","year":"2017","journal-title":"J. Trauma. Stress."},{"issue":"3","key":"10.1016\/j.cct.2024.107741_bb0165","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0033291798006667","article-title":"Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group","volume":"vol. 28","year":"1998","journal-title":"Psychol Med"},{"year":"2013","series-title":"National Center for PTSD, the PTSD Checklist for DSM-5 (PCL-5) \u2013 [Measurement Instrument]","author":"Weathers","key":"10.1016\/j.cct.2024.107741_bb0170"},{"issue":"9","key":"10.1016\/j.cct.2024.107741_bb0175","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"issue":"10","key":"10.1016\/j.cct.2024.107741_bb0180","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.cct.2024.107741_bb0185","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption\u2013II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"key":"10.1016\/j.cct.2024.107741_bb0190","first-page":"1","article-title":"Columbia-suicide severity rating scale screen version: initial screening for suicide risk in a psychiatric emergency department","author":"Bjureberg","year":"2021","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.cct.2024.107741_bb0195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1037\/1082-989X.7.1.83","article-title":"A comparison of methods to test mediation and other intervening variable effects","volume":"7","author":"MacKinnon","year":"2002","journal-title":"Psychol. Methods"},{"year":"2017","series-title":"MedPower: An Interactive Tool for the Estimation of power in Tests of Mediation [Computer Software]","author":"Kenny","key":"10.1016\/j.cct.2024.107741_bb0200"},{"key":"10.1016\/j.cct.2024.107741_bb0205","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/1948550617715068","article-title":"Determining power and sample size for simple and complex mediation models","volume":"8","author":"Schoemann","year":"2017","journal-title":"Soc. Psychol. Personal. Sci."},{"year":"1988","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","key":"10.1016\/j.cct.2024.107741_bb0210"},{"author":"Hayes","key":"10.1016\/j.cct.2024.107741_bb0215"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714424003240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714424003240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T09:01:50Z","timestamp":1733130110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714424003240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":43,"alternative-id":["S1551714424003240"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2024.107741","relation":{},"ISSN":["1551-7144"],"issn-type":[{"type":"print","value":"1551-7144"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and methodology of a randomized clinical trial of quetiapine to reduce central nervous system polypharmacy in veterans with postconcussive syndrome symptoms","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2024.107741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107741"}}